IL1B and neoplasm: Key cytokines such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interferon-gamma (IFN-γ) are critical mediators of tumor progression, immune tolerance, and therapy resistance [22].